UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function

Neurobiology of disease, 2004-06, Vol.16 (1), p.110-123

2004

Volltextzugriff (PDF)

Functional interactions within striatal microcircuit in animal models of Huntington's disease

Neuroscience, 2012-06, Vol.211, p.165-184

2012

Volltextzugriff (PDF)

Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl- D-aspartate responses in medium spiny striatal neurons

Neuroscience, 2001-01, Vol.106 (3), p.579-587

2001

Volltextzugriff (PDF)

Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity

The Journal of neuroscience, 2000-11, Vol.20 (22), p.8443-8451

2000

Volltextzugriff (PDF)

Abnormal Ca2+-Calmodulin-Dependent Protein Kinase II Function Mediates Synaptic and Motor Deficits in Experimental Parkinsonism

The Journal of neuroscience, 2004-06, Vol.24 (23), p.5283-5291

2004

Volltextzugriff (PDF)

Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts

Annals of neurology, 2018-12, Vol.84 (6), p.797-811

2018

Volltextzugriff (PDF)

Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease

Amino acids, 2007-02, Vol.32 (2), p.189-195

2007

Volltextzugriff (PDF)

Therapeutic doses of l‐dopa reverse hypersensitivity of corticostriatal D2‐dopamine receptors and glutamatergic overactivity in experimental parkinsonism

Brain (London, England : 1878), 2004-07, Vol.127 (7), p.1661-1669

2004

Volltextzugriff (PDF)

Dopamine-mediated regulation of corticostriatal synaptic plasticity

Trends in neurosciences (Regular ed.), 2007-05, Vol.30 (5), p.211-219

2007

Volltextzugriff (PDF)

Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment

Brain (London, England : 1878), 2002-12, Vol.125 (12), p.2635-2645

2002

Volltextzugriff (PDF)

Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons

Progress in neurobiology, 2001-04, Vol.63 (6), p.687-696

2001

Volltextzugriff (PDF)

Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism

Neuroscience, 2005, Vol.133 (3), p.831-840

2005

Volltextzugriff (PDF)

Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid

Experimental neurology, 2007-10, Vol.207 (2), p.218-226

2007

Volltextzugriff (PDF)

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

Nature neuroscience, 2003-05, Vol.6 (5), p.501-506

2003

Volltextzugriff (PDF)

Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition

The Journal of neuroscience, 2010-10, Vol.30 (42), p.14182-14193

2010

Volltextzugriff (PDF)

Is pharmacological neuroprotection dependent on reduced glutamate release?

Stroke (1970), 2000-03, Vol.31 (3), p.766-773

2000

Volltextzugriff (PDF)

A Critical Interaction between NR2B and MAGUK in L-DOPA Induced Dyskinesia

The Journal of neuroscience, 2006-03, Vol.26 (11), p.2914-2922

2006

Volltextzugriff (PDF)

A Synaptic Mechanism Underlying the Behavioral Abnormalities Induced by Manganese Intoxication

Neurobiology of disease, 2001-06, Vol.8 (3), p.419-432

2001

Volltextzugriff (PDF)

Molecular mechanisms underlying levodopa-induced dyskinesia

Movement disorders, 2008, Vol.23 (S3), p.S570-S579

2008

Volltextzugriff (PDF)

Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory

Behavioural brain research, 2009-04, Vol.199 (1), p.108-118

2009

Volltextzugriff (PDF)

Dopaminergic control of synaptic plasticity in the dorsal striatum

The European journal of neuroscience, 2001-03, Vol.13 (6), p.1071-1077

2001

Volltextzugriff (PDF)

Experimental Parkinsonism Alters Endocannabinoid Degradation: Implications for Striatal Glutamatergic Transmission

The Journal of neuroscience, 2002-08, Vol.22 (16), p.6900-6907

2002

Volltextzugriff (PDF)

Deficits of glutamate transmission in the striatum of experimental hemiballism

Neuroscience, 2006-11, Vol.143 (1), p.213-221

2006

Volltextzugriff (PDF)

l -DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation

Neurobiology of disease, 2008-02, Vol.29 (2), p.327-335

2008

Volltextzugriff (PDF)

Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study

Experimental neurology, 2003-08, Vol.182 (2), p.461-469

2003

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(82)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function

Functional interactions within striatal microcircuit in animal models of Huntington's disease

Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl- D-aspartate responses in medium spiny striatal neurons

Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity

Abnormal Ca2+-Calmodulin-Dependent Protein Kinase II Function Mediates Synaptic and Motor Deficits in Experimental Parkinsonism

Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts

Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease

Therapeutic doses of l‐dopa reverse hypersensitivity of corticostriatal D2‐dopamine receptors and glutamatergic overactivity in experimental parkinsonism

Dopamine-mediated regulation of corticostriatal synaptic plasticity

Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment

Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons

Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism

Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid

Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia

Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition

Is pharmacological neuroprotection dependent on reduced glutamate release?

A Critical Interaction between NR2B and MAGUK in L-DOPA Induced Dyskinesia

A Synaptic Mechanism Underlying the Behavioral Abnormalities Induced by Manganese Intoxication

Molecular mechanisms underlying levodopa-induced dyskinesia

Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory

Dopaminergic control of synaptic plasticity in the dorsal striatum

Experimental Parkinsonism Alters Endocannabinoid Degradation: Implications for Striatal Glutamatergic Transmission

Deficits of glutamate transmission in the striatum of experimental hemiballism

l -DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation

Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study

Suchergebnisse filtern